U.S. Medical Affairs leverages therapeutic expertise to demonstrate the value of your therapy more effectively.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSThe medical community is not a monolithic entity, but a complex network of relationships and influences. While national scientific key opinion leaders (KOL) and high-volume prescribers are often the focus of pharma companies’ engagement strategies, they may not be the most effective channels to drive treatment and behavioral change.
Christine Aber
Assoc. Director, Thought Leader Engagement – U.S. Medical Affairs, IQVIA
Tim Weckwerth
Principal, Thought Leader Engagement Center of Excellence, IQVIA
Deryk David
Vice President, Intercept Pharmaceuticals
U.S. Medical Affairs leverages therapeutic expertise to demonstrate the value of your therapy more effectively.